Trial intelligence / Profile preview

Tacrolimus pharmacokinetics in the first days after heart and lung transplantation

NL-OMON39373Active, not recruiting

Sponsor
Prof. J. Meulenbelt, MD, PhD Head of department of National Poisons Information Center Intensive Care Center of the division of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Center of Utrecht P.O. Box 85500 3508 GA Utrecht The Netherlands
Start
Apr 2013
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of tacrolimus in graft rejection (2 arms), sponsored by Prof. J. Meulenbelt, MD, PhD Head of department of National Poisons Information Center Intensive Care Center of the division of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Center of Utrecht P.O. Box 85500 3508 GA Utrecht The Netherlands. Started Apr 2013; status: active, not recruiting.

02

Drugs

tacrolimus
03

Conditions

graft rejection

Beyond the preview

Go deeper on NL-OMON39373.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON39373.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call